Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Photonstar Led Group PLC

Market Cap 5.71K 4.92K 4.53K 4.25K 7.98K 540K 8.07K 53.52K 20.85K 264K 21.42K 20.96K 916K P/E Ratio 2019
-0.01x
P/E Ratio 2020 -0.02x
Enterprise Value -78.29K -67.47K -62.13K -58.34K -110K -7.4M -111K -734K -286K -3.62M -294K -288K -12.56M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
76.48%
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Director of Finance/CFO 65 13/05/2021
Chief Tech/Sci/R&D Officer 61 01/01/2025
Director TitleAgeSince
Director/Board Member 45 28/01/2019
Chairman 70 20/05/2019
Director/Board Member 61 13/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-99.07% - - 3.54M
+1.26%+2.15%+14.12%+84.12% 9.23B
+3.22%+14.54%+735.76% - 4.95B
-0.10%-0.39%-9.54%-22.51% 2.83B
+0.05%+2.97%+9.92%-7.14% 2.05B
+9.94%+9.03%-13.66%-6.18% 1.05B
-0.99%+1.71%+54.30%+108.61% 888M
0.00%-1.92%+73.31%+16.19% 859M
-1.91%+3.42%+100.88%+144.81% 815M
+3.24%-0.49%+103.57% - 729M
Average +1.47%+5.14%+118.74%+45.41% 2.6B
Weighted average by Cap. +1.61%+6.83%+171.82%+51.92%

Financials

2019 2020
Net sales - -
Net income -832K -717K -660K -620K -1.16M -78.66M -1.18M -7.8M -3.04M -38.52M -3.12M -3.06M -133M -306K -264K -243K -228K -428K -28.93M -433K -2.87M -1.12M -14.17M -1.15M -1.12M -49.1M
Net Debt -378K -326K -300K -282K -529K -35.74M -534K -3.54M -1.38M -17.5M -1.42M -1.39M -60.65M -84K -72.39K -66.66K -62.59K -118K -7.94M -119K -788K -307K -3.89M -315K -309K -13.48M
Logo Photonstar Led Group PLC
Cizzle Biotechnology Holdings PLC is a United Kingdom-based diagnostics developer of early cancer tests. The Company is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. It is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!